315 related articles for article (PubMed ID: 10636214)
21. Factor V Leiden and prothrombin gene G20210A mutations are uncommon in portal vein thrombosis in India.
Sharma S; Kumar SI; Poddar U; Yachha SK; Aggarwal R
Indian J Gastroenterol; 2006; 25(5):236-9. PubMed ID: 17090840
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of factor V Leiden in children with thrombo-embolism.
Aschka I; Aumann V; Bergmann F; Budde U; Eberl W; Eckhof-Donovan S; Krey S; Nowak-Göttl U; Schobess R; Sutor AH; Wendisch J; Schneppenheim R
Eur J Pediatr; 1996 Dec; 155(12):1009-14. PubMed ID: 8956934
[TBL] [Abstract][Full Text] [Related]
23. Thrombophilic conditions in non-cirrhotic portal vein thrombosis.
Shah SR; DasGupta A; Sharma A; Joshi A; Desai D; Abraham P; Rathi P; Bapat M
Indian J Gastroenterol; 2005; 24(5):205-10. PubMed ID: 16361765
[TBL] [Abstract][Full Text] [Related]
24. Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.
Loew A; Jacob D; Neuhaus P; Riess H
Transplantation; 2005 May; 79(10):1422-7. PubMed ID: 15912114
[TBL] [Abstract][Full Text] [Related]
25. Low prevalence of activated protein C resistance and coagulation factor V Arg506 to Gln mutation among Korean patients with deep vein thrombosis.
Kim TW; Kim WK; Lee JH; Kim SB; Kim SW; Suh C; Lee KH; Lee JS; Seo EJ; Chi HS; Kim SH
J Korean Med Sci; 1998 Dec; 13(6):587-90. PubMed ID: 9886165
[TBL] [Abstract][Full Text] [Related]
26. Inherited thrombophilic risk factors and venous thromboembolism: distinct role in peripheral deep venous thrombosis and pulmonary embolism.
Margaglione M; Brancaccio V; De Lucia D; Martinelli I; Ciampa A; Grandone E; Di Minno G
Chest; 2000 Nov; 118(5):1405-11. PubMed ID: 11083693
[TBL] [Abstract][Full Text] [Related]
27. [Activated protein C resistance and factor V Leiden: clinical interest].
Guermazi S; Znazen R
Pathol Biol (Paris); 2011 Oct; 59(5):281-5. PubMed ID: 19896782
[TBL] [Abstract][Full Text] [Related]
28. Factor V Leiden (FV R506Q) in families with inherited antithrombin deficiency.
van Boven HH; Reitsma PH; Rosendaal FR; Bayston TA; Chowdhury V; Bauer KA; Scharrer I; Conard J; Lane DA
Thromb Haemost; 1996 Mar; 75(3):417-21. PubMed ID: 8701400
[TBL] [Abstract][Full Text] [Related]
29. Laboratory Testing for Activated Protein C Resistance (APCR).
Mohammed S; Favaloro EJ
Methods Mol Biol; 2017; 1646():137-143. PubMed ID: 28804824
[TBL] [Abstract][Full Text] [Related]
30. Prevalence of the Factor V E666D Mutation and Its Correlation With Activated Protein C Resistance in the Chinese Population.
Xin-Guang C; Yong-Qiang Z; Shu-Jie W; Lian-Kai F; Hua-Cong C
Clin Appl Thromb Hemost; 2015 Jul; 21(5):480-3. PubMed ID: 24335247
[TBL] [Abstract][Full Text] [Related]
31. Significantly increased prevalence of factor V Leiden in patients with dural arteriovenous fistulas.
Kraus JA; Stüper BK; Nahser HC; Klockgether T; Berlit P
J Neurol; 2000 Jul; 247(7):521-3. PubMed ID: 10993493
[TBL] [Abstract][Full Text] [Related]
32. Prevalence of activated protein C resistance (Factor V Leiden) in Lagos, Nigeria.
Adeyemo TA; Adediran A; Akinbami AA; Akanmu AS
Niger J Clin Pract; 2012; 15(2):136-41. PubMed ID: 22718159
[TBL] [Abstract][Full Text] [Related]
33. Antiphospholipid antibodies are related to portal vein thrombosis in patients with liver cirrhosis.
Romero Gómez M; Suárez García E; López Lacomba D; Marchante I; Grande L; Castro Fernandez M
J Clin Gastroenterol; 2000 Oct; 31(3):237-40. PubMed ID: 11034005
[TBL] [Abstract][Full Text] [Related]
34. [Relationship of antiphospholipoprotein antibodies of venous thrombi with anticoagulation and fibrinolysis].
Chen ZH; Zheng YZ; Tang J; Li N
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2004 Dec; 12(6):733-6. PubMed ID: 15631650
[TBL] [Abstract][Full Text] [Related]
35. Activated protein C resistance and factor V Leiden in Mexico.
Majluf-Cruz A; Moreno-Hernández M; Ruiz-de-Chávez-Ochoa A; Monroy-García R; Majluf-Cruz K; Guardado-Mendoza R; Molina-Avila I; Isordia-Salas I; Corona-de la Peña N; Vargas-Vorackova F; Vela-Ojeda J; García-Chávez J
Clin Appl Thromb Hemost; 2008 Oct; 14(4):428-37. PubMed ID: 18160617
[TBL] [Abstract][Full Text] [Related]
36. Antiphospholipid antibodies and thrombosis: association with acquired activated protein C resistance in venous thrombosis and with hyperhomocysteinemia in arterial thrombosis.
Kassis J; Neville C; Rauch J; Busque L; Chang ER; Joseph L; Le Comte M; Subang R; Fortin PR
Thromb Haemost; 2004 Dec; 92(6):1312-9. PubMed ID: 15583739
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of a tissue factor dependent factor V assay to detect factor V Leiden: demonstration of high sensitivity and specificity for a generally applicable assay for activated protein C resistance.
Liebman HA; Sutherland D; Bacon R; McGehee W
Br J Haematol; 1996 Dec; 95(3):550-3. PubMed ID: 8943900
[TBL] [Abstract][Full Text] [Related]
38. Janus Kinase-2 Mutation Associated Portal Vein Thrombosis Complicating Liver Cirrhosis and Hepatocellular Carcinoma.
Rabie H; Othman W; Elsabaawy DM; Elshemy EE; Abdelmageed N; Khalaf FA; Bedair HM
Asian Pac J Cancer Prev; 2021 Jan; 22(1):267-275. PubMed ID: 33507708
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous venous thrombosis in a young patient with combined factor V Leiden and lupus anticoagulant.
Lopez FF; Sweeney JD; Blair AJ; Sikov WM
Am J Hematol; 1999 Sep; 62(1):58-60. PubMed ID: 10467279
[TBL] [Abstract][Full Text] [Related]
40. The effect of lupus anticoagulant in the second-generation assay for activated protein C resistance.
Ragland BD; Reed CE; Eiland BM; Tichenor PH; Hudson CL; Fritsma GA; Adler BK; Marques MB
Am J Clin Pathol; 2003 Jan; 119(1):66-71. PubMed ID: 12520699
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
